BPC 157: Experimental Peptide Creates Risk for Athletes The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law BPC 157: Prohibited peptide and unapproved drug in supplements Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law BPC 157: The peptide with big claims and scant evidence STAT